Novavax Inc on Tuesday delayed the start of a latestage U.S. trial of its experimental coronavirus vaccine by roughly a month to the end of November, citing delays in scaling up the manufacturing process.
from Top World News- News18.com https://ift.tt/3jAvVnF
via Click here
from Top World News- News18.com https://ift.tt/3jAvVnF
via Click here
Comments
Post a Comment